Patents by Inventor Eric Morand

Eric Morand has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF FLARES IN LUPUS
    Publication number: 20240026015
    Abstract: The disclosure relates to methods and compositions for the treatment of Systemic Lupus Erythematosus (SLE). The disclosure particular relates to the treatment of flares in SLE across multiple organ domains.
    Type: Application
    Filed: October 7, 2021
    Publication date: January 25, 2024
    Inventors: RUBANA KALYANI, GABRIEL ABREU, RAJENDRA TUMMALA, RICHARD FURIE, ERIC MORAND, ANCA ASKANASE, ED VITAL, KENNETH KALUNIAN, CATHARINA LINDHOLM, EMMANUELLE MAHO, CHRISTI KLEOUDIS
  • COMPOSITIONS AND METHODS FOR TREATING LUPUS
    Publication number: 20230270859
    Abstract: The present invention relates to compositions and methods for the treatment of lupus, particularly systemic lupus erythematosus. The present invention involves, amongst other things, a binding protein comprising a T cell receptor (TCR) ?-chain variable (V? or Valpha) domain and a TCR ?-chain variable (V? or Vbeta) domain, wherein the binding protein is capable of binding to a complex of a fragment of a Smith protein and an HLA-DR15 or HLA-DR3 molecule.
    Type: Application
    Filed: March 19, 2021
    Publication date: August 31, 2023
    Inventors: Joshua OOI, Peter EGGENHUIZEN, Eric MORAND
  • TYPE I INTERFERON INHIBITION IN SYSTEMIC LUPUS ERYTHEMATOSUS
    Publication number: 20220396630
    Abstract: The disclosure relates to methods and compositions for the treatment of Systemic Lupus Erythematosus (SLE). Specifically, the disclosure relates to methods comprising administering to a subject a type I IFN receptor inhibitor.
    Type: Application
    Filed: November 11, 2020
    Publication date: December 15, 2022
    Inventors: Anna BERGLIND, Lilia PINEDA, Raj TUMMALA, Sang-Cheol BAE, Christophe RICHEZ, Anca ASKANASE, Ian BRUCE, Philip BROHAWN, Yoshiya TANAKA, Richard FURIE, Eric MORAND, Gabriel ABREU, Victoria WERTH, Ed VITAL, Michelle KAHLENBERG, David ISENBERG, Ronald Van VOLLENHOVEN, Kenneth KALUNIAN, Rubana KALYANI
  • Novel methods for the treatment of inflammatory diseases
    Publication number: 20070010563
    Abstract: Methods of inhibiting the cytokine or biological activity of Macrophage Migration Inhibitory Factor (MIF) comprising contacting MIF with a compound of formula (I) are provided. The invention also relates to methods of treating diseases or conditions where MIF cytokine or biological activity is implicated comprising administration of compounds of formula (I), either alone or as a part of combination therapy. Novel compounds of formula (I) are also provided for.
    Type: Application
    Filed: April 7, 2004
    Publication date: January 11, 2007
    Inventors: Eric Morand, Magdy Iskander, Colin Skene
  • Therapeutic molecules and methods-1
    Publication number: 20060154977
    Abstract: Methods of inhibiting the cytokine or biological activity of Macrophage Migration Inhibitory Factor (MIF) comprising contacting MIF with a compound of formula (I) as defined herein, is provided. The invention also relates to methods of treating diseases or conditions where MIF cytokine or biological activity is implicated comprising administration of compounds of formula (I), either alone or as part of a combination therapy. Novel heterocyclic compounds are also provided for.
    Type: Application
    Filed: June 6, 2003
    Publication date: July 13, 2006
    Inventors: Eric Morand, Magdy Iskander, Basil Danylec
  • Napththalene derivatives which inhibit the cytokine or biological activity of microphage migration inhibitory factor (mif)
    Publication number: 20060106102
    Abstract: Where Y, R1-R8 and R101-R108 are as defined in the specification. Compounds of formula (II) and methods of inhibiting the cytokine or biological activity of Macrophage Migrating Inhibitory Factor (MIF) comprising contacting MIF with a compound of formula (I) are provided. The invention also relates to methods of treating diseases or conditions where MIF cytokine or biological activity is implicated comprising administration of compounds of formula (1), either alone or as part of a combination therapy.
    Type: Application
    Filed: June 6, 2003
    Publication date: May 18, 2006
    Inventors: Eric Morand, Magdy Iskander, Basil Danylec